BCF Business Law is praised for its expertise in ‘navigating complex matters related to mergers and acquisitions’ for the life sciences sector. The life sciences and healthcare practice is comprised of corporate and commercial specialists as well as patent agents. Clientele of the firm consists of pharmaceutical companies, biotech entites, medical device and digital health companies as well as investors, manufacturers and distributors. Gino Martel leads the Montréal-based team alongside Annie Gauthier. Martel is known for his expertise in private and public financings, M&A and licensing for pharmaceutical, biotech companies and venture capital firms. Gauthier handles corporate transactions for pharmaceutical clients.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'BCF Business Law provides us with comprehensive legal support across all aspects of our medical device business. Its expertise has been particularly valuable in navigating complex matters related to mergers and acquisitions. From due diligence and transaction structuring to negotiation and regulatory compliance, BCF’s strategic guidance has played a critical role in the successful execution of our M&A needs.'
- 'Gino Martel delivers outstanding legal counsel grounded in a strong understanding of the business realities that drive our decisions. He consistently demonstrates the ability to quickly identify the critical elements of any deal we are working on, cutting through complexity to focus on what truly matters. Gino’s advice is not only legally sound but also strategically aligned with our business objectives.'
- 'BCF Business Law takes a multidisciplinary approach which includes professionals with varied expertise, e.g. business, regulatory, intellectual property, etc.'
- 'The firm take a business savvy approach to dealing with legal issues and are cognizant of the business concerns. They provide targeted advice accordingly and are able to explain the level of risk involved in every decision.'
Key clients
- Epitopea
- BSquared Capital
- IRICoR
- Domain Therapeutics
- Triple Hair
- Seido Capital
- Genesis Biotechnology
- Neomabs Biotechnologies
- Cirion Biopharma Research
- Sunshine Biopharma
- Merck Canada
- Organon Canada
Practice head
Gino Martel; Annie Gauthier